Dow Up0.01% Nasdaq Up0.40%

AMAG Pharmaceuticals, Inc. (AMAG)

-NasdaqGS
22.37 Up 0.02(0.09%) 11:24AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 24,802   20,835   21,711   21,616  
Cost of Revenue2,743  2,837  3,326  2,547  
Gross Profit 22,059   17,998   18,385   19,069  
Operating Expenses
Research Development4,540  6,498  6,581  4,530  
Selling General and Administrative16,284  17,491  15,799  14,934  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 1,235   (5,991) (3,995) (395)
Income from Continuing Operations
Total Other Income/Expenses Net269  365  341  250  
Earnings Before Interest And Taxes1,504  (5,626)(3,654)(145)
Interest Expense3,051  1,476   -   -  
Income Before Tax(1,547)(7,102)(3,654)(145)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,547)(7,102)(3,654)(145)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,547) (7,102) (3,654) (145)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,547) (7,102) (3,654) (145)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.